A recent study published in JAMA Health Forum revealed a decrease in the prevalence of obesity in the United States in 2023, marking the first drop since 2013. The study found a slight decrease in mean population BMI in 2023 compared to the previous year, after almost a decade of steady increases. GLP-1 receptor agonists were associated with this decline, particularly in the South. The researchers pointed out potential limitations and the need for further investigation into the factors contributing to this trend, emphasizing that more evidence is needed to fully understand the connection between GLP-1s and obesity rates.
Source link
Obesity rates decline for first time in a decade
